Q-Cells AG, its subsidiary Calyxo GmbH and U.S.-based Solar Fields LLC have merged their activities in the production of cadmium telluride photovoltaic modules. The three companies have been working closely together since Solar Fields exclusively licensed its deposition technology to Q-Cells' 100 % subsidiary Calyxo GmbH.
To accelerate the development and commercialization of the technology and to make optimal use of its economic potential, Q-Cells and Solar Fields have now entered into an arrangement that aligns their businesses and provides for a successful expansion strategy.
Calyxo GmbH is currently building its first prototype facility with a nominal capacity of 25 MW at its company site in Bitterfeld-Wolfen, Germany, which is expected to start production in the first quarter of 2008. Q-Cells says it is committed to securing the financing of future expansion plans and to supporting the further growth ambitions of Calyxo GmbH.